Pictet Asset Management Holding SA »

Tourmaline Bio shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.4M 247k 25.71

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Tourmaline Bio

RA Capital Management
BlackRock
Blue Owl Capital Holdings
Jennison Associates
Qiming U.S. Ventures Management
Nantahala Capital Management
Geode Capital Management
Citadel Advisors
Point72 Asset Management
Pictet Asset Management Holding SA
Schonfeld Strategic Advisors
Northern Trust
Alyeska Investment Group
Woodline Partners
Nan Fung Group Holdings

View all funds holding Tourmaline Bio